人工智能在肝细胞癌预防与临床管理中的应用
肝细胞癌(HCC)是全球第五大常见恶性肿瘤和第三大癌症相关死亡原因,发病率和死亡率持续上升。人工智能(AI)通过机器学习(ML)和深度学习(DL)模型,利用电子健康记录、影像、组织病理和分子标志物等多源数据,提升HCC风险预测、诊断、治疗反应预测和预后评估的准确性。尽管早期结果前景良好,仍需未来研究标准化AI数据并改善结果的通用性和可解释性。
要点
- AI通过ML和DL模型可提升HCC风险预测、检测和治疗反应预测的准确性。
- DL模型基于神经网络结构,可应用于电子健康记录、影像、组织病理和分子标志物等多源数据。
- 未来需标准化AI数据并提高结果的通用性和可解释性。
核心结论
- AI在HCC风险预测、诊断、治疗反应预测和预后评估方面展现出潜力,但需未来研究标准化数据并改善通用性和可解释性。
研究设计与样本
- 综述性文章,未报告系统检索范围。
主要发现
- AI方法包括计算搜索算法、机器学习(ML)和深度学习(DL)模型。
- ML通过计算机重复迭代模型以逐步提高特定任务(如分类结局)的性能。
- DL是ML的子类型,基于受人类大脑神经解剖学启发的神经网络结构。
- 近期数据将DL模型应用于电子健康记录数据、影像模态、组织病理学和分子生物标志物等多种数据源,以提高HCC风险预测、检测和治疗反应预测的准确性。
局限性
- 未来研究仍需标准化AI数据,并改善结果的通用性和可解释性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatocellular carcinoma (HCC) currently represents the fifth most common malignancy and the third-leading cause of cancer-related death worldwide, with incidence and mortality rates that are increasing. Recently, artificial intelligence (AI) has emerged as a unique opportunity to improve the full spectrum of HCC clinical care, by improving HCC risk prediction, diagnosis, and prognostication. AI approaches include computational search algorithms, machine learning (ML) and deep learning (DL) models. ML consists of a computer running repeated iterations of models, in order to progressively improve performance of a specific task, such as classifying an outcome. DL models are a subtype of ML, based on neural network structures that are inspired by the neuroanatomy of the human brain. A growing body of recent data now apply DL models to diverse data sources - including electronic health record data, imaging modalities, histopathology and molecular biomarkers - to improve the accuracy of HCC risk prediction, detection and prediction of treatment response. Despite the promise of these early results, future research is still needed to standardise AI data, and to improve both the generalisability and interpretability of results. If such challenges can be overcome, AI has the potential to profoundly change the way in which care is provided to patients with or at risk of HCC.
引用
- Calderaro J, Seraphin TP, Luedde T, et al. Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma. J Hepatol. 2022. PMID: 35589255. doi:10.1016/j.jhep.2022.01.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。